Skip Navigation Links
Skip Navigation Links

Neoadjuvant Breast Cancer

Neoadjuvant Breast Cancer Trials in St. Louis, MO

Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery (Fulvestrant Provided)  ALTERNATE TRIAL - A011106 (NCT01953588) (MBMC Contact: Henry Robinson 314-996-5865)  

A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chest Wall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy NRG NSABP B-51 / RTOG 1304  (NCT01872975)   (MBMC Contact: Chris Sanders 314-996-5802) (Open at MBMC: RTOG Credentialing Required for Affiliate Sites Prior to Patient Registration {Goldschmidt approved} - See Protocol)






All contents 2007 Heartland Cancer Research St. Louis, MO. All rights reserved. Privacy Policy